Your browser doesn't support javascript.
loading
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Ngai, Lok Lam; Hanekamp, Diana; Janssen, Fleur; Carbaat-Ham, Jannemieke; Hofland, Maaike A M A; Fayed, Mona M H E; Kelder, Angèle; Oudshoorn-van Marsbergen, Laura; Scholten, Willemijn J; Snel, Alexander N; Bachas, Costa; Tettero, Jesse M; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjørn T; Griskevicius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A; Maertens, Johan A; Manz, Markus G; Pabst, Thomas; Passweg, Jakob R; Porkka, Kimmo; Valk, Peter J M; Gradowska, Patrycja; Löwenberg, Bob; de Leeuw, David C; Janssen, Jeroen J W M; Ossenkoppele, Gert J; Cloos, Jacqueline.
Afiliação
  • Ngai LL; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hanekamp D; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Janssen F; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Carbaat-Ham J; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Hofland MAMA; Department of Hematology, Erasmus MC, Rotterdam, Netherlands.
  • Fayed MMHE; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Kelder A; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Oudshoorn-van Marsbergen L; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Scholten WJ; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Snel AN; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Bachas C; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Tettero JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Breems DA; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Fischer T; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Gjertsen BT; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Griskevicius L; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Juliusson G; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • van de Loosdrecht AA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Maertens JA; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Manz MG; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Pabst T; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Passweg JR; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Porkka K; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Valk PJM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Gradowska P; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Löwenberg B; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  • de Leeuw DC; Department of Hematology and Oncology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany.
  • Janssen JJWM; Department of Clinical Science, Haukeland University Hospital, Bergen, Norway.
  • Ossenkoppele GJ; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania.
  • Cloos J; Department of Hematology, Skanes University Hospital, Lund, Sweden.
Blood ; 141(21): 2657-2661, 2023 05 25.
Article em En | MEDLINE | ID: mdl-36898087
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda